Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Diffusion tensor imaging (DTI) biomarkers can be used to quantify microstructural changes in the cerebral white matter (WM) following injury.

Objectives: This prospective single-center study aimed to evaluate whether atlas-based DTI-derived metrics obtained within 1 week after stroke can predict the motor outcome at 3 months.

Methods: Forty patients with small acute stroke (2-7 days after onset) involving the corticospinal tract were included. Each patient underwent magnetic resonance imaging (MRI) within 1 week and at 3 months after stroke, and the changes based on DTI-derived metrics were compared by performing WM tract atlas-based quantitative analysis.

Results: A total of 40 patients were included, with median age 63.5 years and a majority of males (72.5%). Patients were classified into good-prognosis group (mRS 0-2,  = 27) and poor-prognosis group (mRS 3-5,  = 13) by outcome. The median (25-75 percentile) of MD (0.7 (0.6-0.7) vs. 0.7 (0.7-0.8);  = 0.049) and AD (0.6 (0.5, 0.7) vs. 0.7 (0.6, 0.8);  = 0.023) ratios within 1 week were significantly lower in the poor-prognosis group compared to the good-prognosis group. The ROC curve of the combined DTI-derived metrics model showed comparable Youden index (65.5% vs. 58.4%-65.4%) and higher specificity (96.3% vs. 69.2%-88.5%) compared to clinical indexes. The area under the ROC curve of the combined DTI-derived metrics model is comparable to those of the clinical indexes (all  > 0.1) and higher than those of the individual DTI-derived metrics parameters.

Conclusions: Atlas-based DTI-derived metrics at acute stage provide objective information for prognosis prediction of patients with ischemic or lacunar stroke.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10749357.2023.2214977DOI Listing

Publication Analysis

Top Keywords

dti-derived metrics
24
motor outcome
8
prediction patients
8
acute stroke
8
diffusion tensor
8
tensor imaging
8
atlas-based dti-derived
8
good-prognosis group
8
poor-prognosis group
8
roc curve
8

Similar Publications

Diffusion tensor imaging biomarkers for assessing cognitive and physical function in aging.

J Neuroeng Rehabil

July 2025

Department of Biomedical Engineering, Kumoh National Institute of Technology, 350-27 Gumi-Daero, Gumi, Gyeongbuk, 39253, Republic of Korea.

Background: As the global population ages, the decline in cognitive and physical functions presents significant challenges for individuals and healthcare systems. In older adults, conventional assessment methods are often subjective, time-consuming, and influenced by external factors, highlighting the need for objective and efficient evaluation tools. Neuroimaging biomarkers, particularly diffusion tensor imaging (DTI) metrics, offer promising insights into brain structure and function, potentially serving as reliable indicators of functional decline.

View Article and Find Full Text PDF

DTI-Derived Evaluation of Glymphatic System Function in Veterans with Chronic Multisymptom Illness.

AJNR Am J Neuroradiol

June 2025

From the War Related Illness & Injury Study Center (WRIISC) (Y.Z., M.S.M., Y.R., P.J.B., J.W.A., A.J.F), Pain Clinic (J.D.C.), and Polytrauma System of Care (A.J.F.), VA Palo Alto Health Care System, Palo Alto, California, United States; Department of Psychiatry and Behavioral Sciences (M.S.M., Y.R.

Background And Purpose: Chronic Multisymptom Illness includes symptoms of fatigue, pain, sleep difficulties, as well as neurological, respiratory, and gastrointestinal problems and is particularly common in veterans from the 1990-91 Gulf War and the Afghanistan and Iraq Wars. Glymphatic system function may play an important role in the etiopathology of Chronic Multisymptom Illness but has not been addressed. DTI-derived analysis along the perivascular space provides a promising proxy for glymphatic system function by evaluating the status of perivascular space fluid flow.

View Article and Find Full Text PDF

Alzheimer's disease (AD), the leading cause of dementia, poses a growing global health challenge due to its rising prevalence and socioeconomic impact. Investigating metabolic alterations associated with white matter integrity (WMI) could provide critical insights into AD pathogenesis and identify potential therapeutic targets. This cross-sectional study explored the associations between amino acid (AA) profiles, assessed via ultra-high-performance liquid chromatography (UHPLC), and WMI metrics derived from diffusion tensor imaging (DTI) in individuals across the AD continuum.

View Article and Find Full Text PDF

White matter trajectories in Down syndrome and Alzheimer's disease: Insights from diffusion tensor-based morphometry.

Alzheimers Dement

June 2025

Institute of Psychiatry, Psychology & Neuroscience, Department of Forensic and Neurodevelopmental Sciences, King's College London, London, UK.

Introduction: Diffusion magnetic resonance imaging studies investigating Down syndrome (DS) and Alzheimer's disease (AD) have mainly relied on white matter (WM) skeleton-based techniques, potentially overlooking broader WM architecture.

Method: We applied diffusion tensor-based morphometry (D-TBM), a novel whole-volume WM registration technique, to characterize WM properties in DS. Between- and within-group analyses were conducted in 51 adults with DS and 35 controls, divided into two age groups, using diffusion tensor imaging (DTI)-derived metrics and local volumetric changes.

View Article and Find Full Text PDF

Background: Pediatric kidney transplant recipients require periodic biopsy for active surveillance to prolong allograft half-life, and non-invasive MR imaging markers are needed but understudied. Here we aimed to determine the feasibility of MR diffusion tensor imaging (DTI) on pediatric kidney transplant recipients, compare transplanted kidneys DTI values to healthy controls, and correlate DTI values with allograft histopathology.

Methods: Single-center prospective study of pediatric (< 18 years of age) kidney transplant recipients undergoing biopsies and healthy controls between February 2020 and October 2023.

View Article and Find Full Text PDF